LogicBio Therapeutics (LOGC) Reports Publication of Pre-Clinical Results for mLB-001 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ LogicBio Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today provided updates around its SUNRISE Phase 1/2.
LEXINGTON, Mass., Dec. 22, 2021 /PRNewswire/ LogicBio Therapeutics, Inc. , a clinical-stage genetic medicine company, today provided updates around its SUNRISE Phase 1/2 clinical trial. | December 22, 2021